Current therapeutic options in the treatment of rheumatoid arthritis

• Verfasst von: Köhler, Birgit M. [VerfasserIn]
• Verfasst von: Günther, Janine [VerfasserIn]
• Verfasst von: Kaudewitz, Dorothee [VerfasserIn]
• Verfasst von: Lorenz, Hanns-Martin [VerfasserIn]
• Titel: Current therapeutic options in the treatment of rheumatoid arthritis
• Verf.angabe: Birgit M. Köhler, Janine Günther, Dorothee Kaudewitz and Hanns-Martin Lorenz
• E-Jahr: 2019
• Jahr: 28 June 2019
• Umfang: 15 S.
• Fussnoten: Published: 28 June 2019 ; Gesehen am 25.05.2020
• Titel Quelle: Enthalten in: Journal of Clinical Medicine
• Ort Quelle: Basel : MDPI, 2012
• Jahr Quelle: 2019
• Band/Heft Quelle: 8(2019,7) Artikelnummer 938, 15 Seiten
• ISSN Quelle: 2077-0383
• DOI: doi:10.3390/jcm8070938
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: DMARD
• Sach-SW: MTX
• Sach-SW: Rheumatoid Arthritis
• Sach-SW: Therapy
• Sach-SW: Tumor Necrosis Factor-Alpha Inhibitors
• K10plus-PPN: 1698738811

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of the joints. Untreated RA leads to a destruction of joints through the erosion of cartilage and bone. The loss of physical function is the consequence. Early treatment is important to control disease activity and to prevent joint destruction. Nowadays, different classes of drugs with different modes of action are available to control the inflammation and to achieve remission. In this review, we want to discuss differences and similarities of these different drugs.